Symphony in the crowd: Key genetic alterations in prostate cancer

Neshat Masud1

  • 1Department of Pharmacology University of Louisiana at Monroe Monroe LA USA.

Cancer Innovation
|December 13, 2023
PubMed

Insights

Understanding prostate cancer (PCa) genetic alterations is key to overcoming treatment resistance. This review highlights common genetic changes impacting androgen receptor (AR) signaling in PCa.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Androgen receptor (AR) signaling is a primary target for prostate cancer (PCa) therapy.
  • Therapeutic resistance frequently emerges due to genetic alterations in prostate cells.
  • Identifying these key genetic changes is crucial for developing effective treatment strategies.

Purpose of the Study:

  • To review the critical genes and genetic alterations driving altered prostate cancer environments.
  • To provide insights into the genetic basis of treatment resistance in PCa.

Main Methods:

  • Literature review of genetic alterations in prostate cancer.
  • Analysis of common genetic changes affecting AR signaling and tumor suppression.

Main Results:

  • Common genetic alterations include TMPRSS2-ETS gene fusions, PTEN and TP53 mutations/deletions, and AR amplification/splicing.
  • Altered DNA repair genes also contribute to the evolving prostate cancer landscape.
  • These changes lead to distinct androgen differentiation states and treatment resistance.

Conclusions:

  • Recognizing key genetic alterations is essential for advancing PCa therapeutic regimes.
  • Understanding these genetic drivers can help predict and overcome treatment resistance.
  • Further research into these genetic changes will improve PCa management.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K